Chronic Phase CML
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| ELVN-001 for the Treatment of Chronic Myeloid Leukemia With and Without T315I Mutation in Japanese Participants (NCT06787144) | Enliven Therapeutics | 2025-01-23 |
| Pilot Study to Assess Telemonitoring of Gleevec (Imatinib Mesylate) or Tasigna (Niltinib) Therapy (NCT01490775) | Rex Cancer Center, Raleigh, NC | 2009-04-01 |
Track Chronic Phase CML automatically
Every clearance here is in the API, with alerts when new ones post.